RiaSTAP

CSL Behring Patient Assistance Program Patient Guide: How to Get RiaSTAP at Low or No Cost

RiaSTAP (fibrinogen concentrate (human)) is a vital medication used to treat congenital fibrinogen deficiency by replacing missing or low fibrinogen levels in the blood, helping prevent and control bleeding episodes.[1][5] The CSL Behring Patient Assistance Program offers this therapy at no cost to qualified patients who are uninsured, underinsured, or unable to afford their prescribed treatment, making life-saving care accessible without strict income limits.[1][5]

About RiaSTAP

RiaSTAP is an intravenous concentrate derived from human plasma, indicated for acute bleeding episodes and perioperative management in patients with congenital fibrinogen deficiency.[5] It works by providing the clotting protein fibrinogen, which is essential for blood to clot properly. Administered by a healthcare professional in a hospital or clinic setting, it typically requires infusion over 5-10 minutes, with dosing based on the patient's weight and fibrinogen levels.[5] Common side effects may include headache, nausea, or allergic reactions, so discuss risks with your doctor. Always follow your prescriber's instructions, as RiaSTAP must be used per its package insert.[2]

This program ensures patients facing financial barriers can access RiaSTAP without delay, supporting better health outcomes during critical times.[1][5]

Who Qualifies?

The program targets patients who are uninsured, underinsured, or cannot afford their prescribed RiaSTAP therapy.[1][5] Unlike many assistance programs, there are no specific income thresholds listed, such as Federal Poverty Level (FPL) percentages or household size limits. Qualification focuses on financial need and medical necessity rather than rigid income guidelines.[1][5] You must be a U.S. resident (excluding Puerto Rico and other territories for some related programs).[2][4]

Eligible patients typically include:

• Those without any health insurance covering RiaSTAP.
• Underinsured individuals facing high out-of-pocket costs.
• Anyone whose financial situation prevents affording therapy, even with partial coverage.[1][5]

Your doctor must confirm RiaSTAP is medically necessary with no free trial history contraindications.[2] Government insurance like Medicare or Medicaid may affect eligibility—see the Insurance Requirements section below.[2]

Income Eligibility Breakdown

The CSL Behring Patient Assistance Program stands out for its flexible, case-by-case income evaluation without published fixed thresholds.[1][5] Here's a comparison table highlighting this approach versus typical programs:

Table based on 2026 FPL estimates for illustration; CSL Behring does not use FPL cutoffs. Submit income proof for personalized assessment.[3]

Insurance Requirements

This program is designed for uninsured, underinsured, or those unable to afford therapy.[1][5] Patients with commercial insurance may qualify if costs are prohibitive, but government programs like Medicare, Medicaid, Tricare, or SCHIPs often disqualify you, as product must be purchased from specialty pharmacies, hemophilia centers, or hospitals.[2] Check with program staff: call (800) 676-4266 to verify.[5] Related co-pay programs require commercial coverage and exclude Medicare.[4]

Step-by-Step Application Process

Applying is straightforward with multiple methods available.[1] Here's how:

1. Consult Your Doctor: Get a prescription for brand-name RiaSTAP and discuss medical necessity. Your prescriber completes key form sections.[2][3]

2. Gather Documents: Prepare the Patient Assistance Qualification Form, income proof (W2, pay stubs, notarized income letter), and prescription.[3]

3. Submit Application:

   • Phone: Call (800) 676-4266 for guidance, enrollment help, or to start verbally.[1][5]
   • Form Download: Visit CSL Behring's site or request the form via phone; prescriber signs it.[2][3]
   • Fax/Mail: Send to provided address after phone consultation.[3]

4. Program Review: CSL Behring verifies eligibility, insurance status, and need. Expect case manager support.[1][7]

5. Approval Notification: If approved, medication ships free.[1]

Your signature authorizes CSL Behring to check insurance and enroll you in support services.[2][6]

Timeline and Delivery

Processing time varies but aims for quick access; call for status updates.[1] Once approved, RiaSTAP is shipped directly to your home or physician's office via specialty pharmacy.[1] Related programs note enrollment verification upon criteria met.[8] Refills follow reauthorization if required—contact (800) 676-4266.[5]

Alternatives if Denied

If ineligible:

• Explore CSL Behring Assurance for insurance lapses (call 866-415-2164).[8]
• Co-Pay Programs for commercial insurance (888-508-6978).[4]
• Other foundations like Patient Access Network or HealthWell.
• State programs or hemophilia treatment centers.
• Discuss generics/biosimilars (none listed for RiaSTAP).[1]

Reapply if circumstances change.[1]

Disclaimer

This guide is for informational purposes based on available program details as of 2026.[1][5] Eligibility, terms, and availability can change; CSL Behring reserves rights to modify or end the program.[2] Always contact (800) 676-4266 or visit official sites for latest info. Not medical advice—consult your healthcare provider. Income estimates illustrative; actual qualification case-specific. Word count: 1028.